Retatrutide 30mg Retatrutide Mechanism of Action in Research Models Retatrutide functions as a balanced triple agonist, binding to GLP-1, GIP, and glucagon receptors with nanomolar affinity: GIP receptor: 0.064 nM GLP-1 receptor: 0.775 nM Glucagon receptor: 5.79 nM In research models, retatrutide activates several metabolic pathways: 1
The number of doses depends on the vial strength, dilution, and your chosen dose
Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, et al
However, the buffering capacity becomes limited as impairment of SAT expansion causes IR [22, 23, 24] as the excess fat are deposited in the visceral adipose tissue (VAT) as well as ectopically in the skeletal muscle, liver, kidney, and heart tissues [25]